<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Platelet integrin alpha IIb beta 3 (GPIIb/IIIa) plays a central role in the initiation of <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, but its contribution to disseminated microvascular <z:mp ids='MP_0005048'>thrombosis</z:mp> is less well defined </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, <z:mp ids='MP_0002169'>wild-type</z:mp> mice (beta 3(+/+)), beta 3-integrin-deficient mice (beta 3(-/-)), and <z:mp ids='MP_0002169'>wild-type</z:mp> mice treated with a hamster monoclonal antibody (1B5) that blocks murine alpha IIb beta 3 function were tested in models of large-vessel and microvascular <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>In the large-vessel model, <z:chebi fb="2" ids="30808">ferric chloride</z:chebi> was used to injure the carotid artery, and the time to <z:mp ids='MP_0005048'>thrombosis</z:mp> was measured </plain></SENT>
<SENT sid="3" pm="."><plain>In beta 3(+/+) mice, the median time to occlusion was 6.7 minutes, whereas occlusion did not occur in any of the beta 3(-/-) mice tested (P &lt;.001) </plain></SENT>
<SENT sid="4" pm="."><plain>Fab and F(ab')(2) fragments of 1B5 increased the median time to occlusion </plain></SENT>
<SENT sid="5" pm="."><plain>To initiate systemic intravascular <z:mp ids='MP_0005048'>thrombosis</z:mp>, prothrombotic agents were administered intravenously, and platelet <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation was monitored by the decrease in circulating platelet count </plain></SENT>
<SENT sid="6" pm="."><plain>Three minutes after the injection of <z:chebi fb="3" ids="16335">adenosine</z:chebi> <z:chebi fb="2" ids="18361">diphosphate</z:chebi> (<z:chebi fb="13" ids="16761">ADP</z:chebi>), collagen + <z:chebi fb="2" ids="28918">epinephrine</z:chebi>, or tissue factor, the platelet counts in beta 3(+/+) mice decreased by 289, 424, and 429 x 10(3)/microL, respectively. beta 3(-/-) mice and <z:mp ids='MP_0002169'>wild-type</z:mp> mice pretreated with 1B5 Fab (1 mg/kg, IP) were nearly completely protected from the effects of <z:chebi fb="13" ids="16761">ADP</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, beta 3(-/-) mice were only partially protected from the effects of collagen + <z:chebi fb="2" ids="28918">epinephrine</z:chebi> and minimally protected from the effects of tissue factor </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases, less fibrin became deposited in the lungs of beta 3(-/-) mice than in <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that though alpha IIb beta 3 plays a dominant role in large-vessel <z:mp ids='MP_0005048'>thrombosis</z:mp>, it plays a variable role in systemic intravascular <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>(Blood </plain></SENT>
<SENT sid="11" pm="."><plain>2001;98:1055-1062) </plain></SENT>
</text></document>